Literature DB >> 24072848

Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals.

Christina Psomas1, Jean-Philippe Lavigne, Claudine Barbuat, Selma Trabelsi, Jade Ghosn, Caroline Lascoux-Combe, Philippe Flandre, Lise Cuzin, Jacques Reynes, Brigitte Autran, Pierre Corbeau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24072848     DOI： 10.1182/blood-2013-06-507012

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?

Authors:  A Saez-Cirion; B Jacquelin; F Barré-Sinoussi; M Müller-Trutwin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-05-12       Impact factor: 6.237

2.  Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND).

Authors:  Lishomwa C Ndhlovu; Tracie Umaki; Glen M Chew; Dominic C Chow; Melissa Agsalda; Kalpana J Kallianpur; Robert Paul; Guangxiang Zhang; Erika Ho; Nancy Hanks; Beau Nakamoto; Bruce T Shiramizu; Cecilia M Shikuma
Journal:  J Neurovirol       Date:  2014-09-17       Impact factor: 2.643

3.  Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial.

Authors:  Steven F L van Lelyveld; Julia Drylewicz; Maaike Krikke; Ellen M Veel; Sigrid A Otto; Clemens Richter; Robin Soetekouw; Jan M Prins; Kees Brinkman; Jan Willem Mulder; Frank Kroon; Ananja Middel; Jori Symons; Annemarie M J Wensing; Monique Nijhuis; José A M Borghans; Kiki Tesselaar; Andy I M Hoepelman
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

4.  Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients.

Authors:  Jean-Jacques Tudesq; Catherine Dunyach-Remy; Christophe Combescure; Régine Doncesco; Didier Laureillard; Jean-Philippe Lavigne; Albert Sotto
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

5.  Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.

Authors:  Mehwish Younas; Christina Psomas; Christelle Reynes; Renaud Cezar; Lucy Kundura; Pierre Portales; Corinne Merle; Nadine Atoui; Céline Fernandez; Vincent Le Moing; Claudine Barbuat; Olivier Moranne; Albert Sotto; Robert Sabatier; Pascale Fabbro; Thierry Vincent; Catherine Dunyach-Remy; Audrey Winter; Jacques Reynes; Jean-Philippe Lavigne; Pierre Corbeau
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

6.  Identification of distinct immune activation profiles in adult humans.

Authors:  Renaud Cezar; Audrey Winter; Delphine Desigaud; Manuela Pastore; Lucy Kundura; Anne-Marie Dupuy; Chantal Cognot; Thierry Vincent; Christelle Reynes; Catherine Dunyach-Remy; Jean-Philippe Lavigne; Robert Sabatier; Patricia Le Merre; Elisabeth Maggia; Pierre Corbeau
Journal:  Sci Rep       Date:  2020-11-30       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.